Members of the B7 family have moved to the forefront of cancer research for their underlying involvement in tumorigenesis [17] and tumor recognition [16] and for their role as regulators of immune responses and immunotherapy outcomes, such as B7-H1, also known as PD-L1, one of the most discussed checkpoint inhibitors in recent years [28]. This evidence concerns the gene CD274 and cancer.